CAS 33996-58-6

α-Ethyl-2-oxo-1-pyrrolidineacetamide

Description:

α-Ethyl-2-oxo-1-pyrrolidineacetamide, with the CAS number 33996-58-6, is a chemical compound characterized by its pyrrolidine ring structure, which is a five-membered cyclic amine. This compound features an ethyl group and an acetamide functional group, contributing to its unique reactivity and properties. It typically exhibits moderate solubility in polar solvents due to the presence of the amide group, which can engage in hydrogen bonding. The ketone functionality (2-oxo) adds to its reactivity, making it a potential intermediate in organic synthesis. The compound may also display biological activity, which could be of interest in medicinal chemistry. Its structural features suggest potential applications in pharmaceuticals or as a building block in the synthesis of more complex molecules. As with many organic compounds, handling should be done with care, considering safety data and potential hazards associated with its use.

Formula: C₈H₁₄N₂O₂

InChI: InChI=1/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)

InChI key: InChIKey=HPHUVLMMVZITSG-UHFFFAOYSA-N

SMILES: C(C(N)=O)(CC)N1C(=O)CCC1

Synonyms:

• (±)-a-Ethyl-2-oxo-1-pyrrolidineacetamide
• 1-Pyrrolidineacetamide, Alpha-Ethyl-2-Oxo-
• 1-Pyrrolidineacetamide, α-ethyl-2-oxo-
• 2-(2-Oxo-1-pyrrolidinyl)butanamide
• 2-(2-Oxopyrrolidin-1-yl)butanamide
• Etirancetam
• Ucb 6474
• Etiracetam
• (+-)-1-pyrrolidineacetamid
• racemic-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
• LevetiracetaM RaceMic Mixture EtiracetaM
• Etiracetam USP/EP/BP
• 2(RS)-(2-Oxopyrrolidin-1-yl)butyramide
• 2-(2-Oxopyrrolidin-1-yl)butyramide
• Levetiracetam Impurity 24/Levetiracetam Racemate/Etiracetam/(R)-2-(2-oxopyrrolidin-1-yl)butanamide
• Levetiracetam Racemate
• (+-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
• Levetiracetam Racemic Mixture (15 mg)
• (RS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
• Levetiracetam Racemate (Etiracetam)
• Levetiracetam Impurity 5（Levetiracetam Racemate）
• SALOR-INT L127760-1EA

Levetiracetam Racemic Mixture

CAS: 33996-58-6

Formula: C₈H₁₄N₂O₂

Molecular weight: 170.21

Ref: ST-EA-CP-L13009

Levetiracetam Racemic Mixture (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide)

CAS: 33996-58-6

Lactams, nesoi

Formula: C₈H₁₄N₂O₂

Color and Shape: White Off-White Powder

Molecular weight: 170.10553

Ref: 45-1359415

rac-Levetiracetam

CAS: 33996-58-6

Formula: C₈H₁₄N₂O₂

Molecular weight: 170.21

Ref: 4Z-L-0522

Etiracetam

Controlled Product

CAS: 33996-58-6

Applications A nootropic drug that produced a significant increase in β-wave activity and stimulated α-wave activity dose-dependently. It has been used in studies to alleviate the effects of memory retrieval deficits in rats.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Sara, S.J.: Psychopharmacology, 68, 235 (1980); Wolthuis, O.L.: Pharamacol. Biochem. Behav., 15, 247 (1981); Saletu, B. et al.: Prog. Neuro-Psychopharmacol., 4, 469 (1980);

Formula: C₈H₁₄N₂O₂

Color and Shape: White To Off-White

Molecular weight: 170.21

Ref: TR-E932970

Etiracetam

Controlled Product

CAS: 33996-58-6

Etiracetam is an antiepileptic drug that is used in the treatment of epilepsy. It is a chiral compound, which means it has two different forms that are mirror images of each other. Etiracetam binds to the enzyme gamma-aminobutyric acid (GABA) receptor, blocking the binding of GABA and inhibiting its effect on postsynaptic neurons. This drug also inhibits protein transport and interacts with drugs such as levetiracetam and phenytoin, which may lead to adverse effects or toxicity. Etiracetam has shown efficacy in treating specific types of epilepsy such as myoclonic astatic epilepsy and Lennox-Gastaut syndrome, but not generalized epilepsy.

Formula: C₈H₁₄N₂O₂

Purity: Min. 95%

Molecular weight: 170.21 g/mol

Ref: 3D-FE23190